ClinicalTrials.govpublic full text
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
leukemia, acute myeloid leukemia, aml, cytarabine, idarubicin, cytarabine, idarubicin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800386
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.